Carlos Rodríguez‐galindo
#157,967
Most Influential Person Now
Carlos Rodríguez‐galindo's AcademicInfluence.com Rankings
Carlos Rodríguez‐galindophilosophy Degrees
Philosophy
#8993
World Rank
#12482
Historical Rank
Logic
#5999
World Rank
#7469
Historical Rank

Download Badge
Philosophy
Why Is Carlos Rodríguez‐galindo Influential?
(Suggest an Edit or Addition)Carlos Rodríguez‐galindo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. (2016) (914)
- Inactivation of the p53 pathway in retinoblastoma (2006) (585)
- Langerhans Cell Histiocytosis (LCH): Guidelines for Diagnosis, Clinical Work-Up, and Treatment for Patients Till the Age of 18 Years (2012) (464)
- Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. (2004) (412)
- The genomic landscape of pediatric Ewing sarcoma. (2014) (380)
- Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. (2009) (345)
- Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma (2014) (335)
- Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma (2012) (277)
- Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge. (2015) (271)
- Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. (2018) (263)
- Soft tissue sarcoma across the age spectrum: A population‐based study from the surveillance epidemiology and end results database (2011) (242)
- Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors (2015) (214)
- Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005 (2009) (205)
- A proposal for an international retinoblastoma staging system (2006) (203)
- Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors (2017) (187)
- Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. (2003) (184)
- Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study. (2014) (178)
- Childhood cancer burden: a review of global estimates. (2019) (176)
- Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. (2009) (173)
- Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators (2010) (166)
- Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study. (2016) (156)
- Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO) (2019) (155)
- Analysis of prognostic factors in ewing sarcoma family of tumors (2007) (155)
- Impact of an education program on late diagnosis of retinoblastoma in Honduras (2007) (154)
- Survival after recurrence of Ewing Tumors (2002) (153)
- Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation (2005) (152)
- Treatment of intraocular retinoblastoma with vincristine and carboplatin. (2003) (152)
- Global challenges in pediatric oncology (2013) (151)
- The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017 (2019) (147)
- Incidence of Childhood and Adolescent Melanoma in the United States: 1973–2009 (2013) (145)
- Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy (2014) (144)
- Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study. (2015) (139)
- c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-XL (2003) (139)
- Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. (2007) (135)
- Carboplatin-associated ototoxicity in children with retinoblastoma. (2012) (129)
- Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck (2016) (128)
- Clinical field testing of an enhanced-activity intervention in hospitalized children with cancer. (2007) (125)
- Prognostic factors for local and distant control in Ewing sarcoma family of tumors. (2008) (123)
- Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences (2014) (122)
- Coexpression of normally incompatible developmental pathways in retinoblastoma genesis. (2011) (121)
- Biology, clinical characteristics, and management of adrenocortical tumors in children (2005) (117)
- Retinoblastoma: One World, One Vision (2008) (117)
- Recent advances in the understanding of Langerhans cell histiocytosis (2012) (115)
- High‐dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma (2004) (112)
- Salivary gland carcinomas in children and adolescents: A population‐based study, with comparison to adult cases (2011) (111)
- Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review (2014) (107)
- Sustainable care for children with cancer: a Lancet Oncology Commission. (2020) (107)
- Distinct features of colorectal cancer in children and adolescents (2010) (106)
- Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group. (2014) (103)
- Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. (2006) (99)
- Clinical Characteristics and Treatment of Langerhans Cell Histiocytosis. (2015) (99)
- Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. (2018) (98)
- The International Pediatric Adrenocortical Tumor Registry initiative: Contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors (2012) (98)
- The COVID‐19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global (2020) (97)
- Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. (2014) (97)
- Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States. (2015) (96)
- Early advice on managing children with cancer during the COVID‐19 pandemic and a call for sharing experiences (2020) (96)
- Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors (2010) (95)
- PET-CT in pediatric Langerhans cell histiocytosis (2007) (94)
- Genomic landscape of pediatric adrenocortical tumors (2015) (94)
- Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers (2014) (92)
- Langerhans Cell histiocytosis. (2020) (92)
- UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan. (2007) (92)
- Differential features of nasopharyngeal carcinoma in children and adults: A SEER study (2010) (91)
- Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. (2001) (88)
- Treatment of metastatic retinoblastoma. (2003) (84)
- Preradiation chemotherapy with methotrexate, cisplatin, 5‐fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma (2005) (84)
- Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative (2016) (84)
- Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma (2013) (83)
- Metastatic osteosarcoma (2006) (82)
- Asociación de Hemato‐Oncología Pediátrica de Centro América (AHOPCA): A model for sustainable development in pediatric oncology (2014) (79)
- Primary Ewing tumor of the vertebrae: clinical characteristics, prognostic factors, and outcome. (2001) (76)
- Outcome after local recurrence of osteosarcoma (2004) (73)
- Rodriguez-Galindo C, Spunt SL, Pappo AS. Treatment of Ewing sarcoma family of tumors: Current status and outlook for the future. Med Pediatr Oncol 2003;40:276–287 (2003) (72)
- Treating Childhood Cancer in Low- and Middle-Income Countries (2015) (72)
- Prognostic factors and long‐term outcomes of childhood nasopharyngeal carcinoma (2011) (71)
- Ethnic, Racial, and Socioeconomic Disparities in Retinoblastoma. (2015) (71)
- Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors. (2004) (70)
- Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors. (2006) (69)
- Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. (2020) (69)
- Extranodal Rosai-Dorfman Disease in Children (2004) (69)
- Trilateral retinoblastoma: Potentially curable with intensive chemotherapy (2010) (68)
- Global efforts toward the cure of childhood acute lymphoblastic leukaemia. (2018) (67)
- Hemangiopericytoma in children and infants (2000) (67)
- Treatment of retinoblastoma: Current status and future perspectives (2007) (66)
- Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study (2021) (66)
- Classification of treatment-related mortality in children with cancer: a systematic assessment. (2015) (65)
- A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma (2009) (64)
- Genomic landscape of paediatric adrenocortical tumours (2016) (64)
- Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors (2005) (63)
- 6.O.06 COMPARING CHILDREN AND ADULTS WITH SYNOVIAL SARCOMA IN THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM, 1983 TO 2005: AN ANALYSIS OF 1268 PATIENTS (2010) (63)
- Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma. (2014) (62)
- The Incidence and Prognosis of Osteosarcoma Skip Metastases (2004) (62)
- Scaling up cancer care for children without medical insurance in developing countries: The case of Mexico (2013) (62)
- Efficacy of combined surgery and irradiation for localized Ewings sarcoma family of tumors (2004) (61)
- The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma. (1999) (60)
- Fractures in Pediatric Ewing Sarcoma (2001) (60)
- Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study (2021) (60)
- Second cancers in patients with the Ewing sarcoma family of tumours. (2008) (59)
- Team management, twinning, and telemedicine in retinoblastoma: A 3‐tier approach implemented in the first eye salvage program in Jordan (2008) (59)
- Metastatic osteosarcoma. (2020) (59)
- Validation of a Pediatric Early Warning Score in Hospitalized Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients (2016) (57)
- Improved outcomes after successful implementation of a pediatric early warning system (PEWS) in a resource‐limited pediatric oncology hospital (2017) (57)
- Ethnicity, race, and socioeconomic status influence incidence of langerhans cell histiocytosis (2015) (56)
- CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH‐associated neurodegeneration and mass lesions (2018) (56)
- Use of Preclinical Models to Improve Treatment of Retinoblastoma (2005) (56)
- Protocol‐based treatment for children with cancer in low income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)—Part II (2007) (55)
- Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration. (2015) (55)
- Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition. (2019) (55)
- Is primitive neuroectodermal tumor of the kidney a distinct entity? (1997) (54)
- Natural history of moderate aplastic anemia in children (2004) (54)
- Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil (2006) (54)
- Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors. (2009) (54)
- Episcleral plaque brachytherapy for retinoblastoma (2004) (53)
- Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas (2018) (53)
- Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma (2016) (53)
- World disparities in risk definition and management of retinoblastoma: A report from the International Retinoblastoma Staging Working Group (2008) (52)
- Retinoblastoma in Central America: Report from the Central American Association of Pediatric Hematology Oncology (AHOPCA) (2012) (52)
- Development of retinoblastoma programs in Central America (2009) (52)
- Clinical use of topoisomerase I inhibitors in anticancer treatment. (2000) (52)
- Caveolin-1 Modulates the Ability of Ewing's Sarcoma to Metastasize (2010) (50)
- Soft tissue sarcomas in the first year of life. (2010) (50)
- Osteosarcoma of the pelvis in children and young adults: The St. Jude Children's Research Hospital experience (2005) (50)
- Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines. (2016) (46)
- Upfront window vincristine/irinotecan treatment of high‐risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee (2017) (46)
- STAT3 is activated in a subset of the Ewing sarcoma family of tumours (2006) (46)
- Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors. (2000) (46)
- Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. (2019) (45)
- Treatment of children with Langerhans cell histiocytosis with 2‐chlorodeoxyadenosine (2002) (45)
- Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial. (2019) (45)
- Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans. (2010) (44)
- Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. (2011) (44)
- Integrated genetic and pharmacologic interrogation of rare cancers (2016) (43)
- Validation of a pediatric early warning system for hospitalized pediatric oncology patients in a resource‐limited setting (2017) (43)
- Paediatric extracranial germ-cell tumours. (2016) (41)
- Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. (2017) (40)
- Neonatal alveolar rhabdomyosarcoma with skin and brain metastases (2001) (40)
- Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleation. (2006) (39)
- Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity (2012) (39)
- PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma (2012) (38)
- Ewing sarcoma‐family tumors that arise after treatment of primary childhood cancer (2006) (38)
- Malignant transformation of irradiated craniopharyngioma in children: report of 2 cases. (2010) (38)
- Neuronal differentiation and synaptogenesis in retinoblastoma. (2007) (38)
- A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumors (2009) (38)
- Barriers to effective treatment of pediatric solid tumors in middle‐income countries: Can we make sense of the spectrum of nonbiologic factors that influence outcomes? (2014) (37)
- The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2021) (36)
- Treatment of Refractory Osteosarcoma With Fractionated Cyclophosphamide and Etoposide (2002) (35)
- Children's Oncology Group's 2013 blueprint for research: Rare tumors (2013) (34)
- Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway (2016) (34)
- Infections in children and young adults with bone malignancies undergoing limb‐sparing surgery (2005) (34)
- Reducing irinotecan‐associated diarrhea in children (2008) (34)
- Pathologic Risk-based Adjuvant Chemotherapy for Unilateral Retinoblastoma Following Enucleation (2014) (33)
- Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma. (2009) (33)
- Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma. (2017) (33)
- Clinical Trials Infrastructure as a Quality Improvement Intervention in Low- and Middle-Income Countries (2016) (33)
- Second malignancies in patients with Ewing Sarcoma Family of Tumors: A population-based study (2010) (33)
- Pediatric sarcoma in Central America (2013) (32)
- Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid tumors (2012) (32)
- An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population‐Based Evidence for a Cancer Predisposition Syndrome? (2016) (31)
- Mutations in Hedgehog pathway genes in fetal rhabdomyomas (2013) (31)
- Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma (2015) (31)
- Orbital Involvement in Langerhans Cell Histiocytosis (2009) (31)
- Clofarabine in refractory Langerhans cell histiocytosis (2008) (30)
- Socioeconomic Impact of Modern Multidisciplinary Management of Retinoblastoma (2006) (30)
- Childhood Hemangiopericytoma: Review of St Jude Children's Research Hospital (2011) (30)
- Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcoma. (2010) (30)
- Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma. (2006) (30)
- Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium. (2018) (30)
- The presentation and management of mandibular tumors in the pediatric population (2013) (30)
- Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian Collaborative Study Group for Ewing Sarcoma Family Tumors—EWING1 (2015) (30)
- Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America (2019) (29)
- The Addition of Ifosfamide/Etoposide to Cisplatin/Teniposide Improves the Survival of Children With Retinoblastoma and Orbital Involvement (2007) (29)
- Clofarabine salvage therapy for refractory high‐risk langerhans cell histiocytosis (2013) (28)
- XAF1 as a modifier of p53 function and cancer susceptibility (2020) (27)
- Trends in incidence of primary cutaneous malignancies in children, adolescents, and young adults: A population‐based study (2014) (27)
- Ocular Preservation After 36 Gy External Beam Radiation Therapy for Retinoblastoma (2002) (27)
- Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma Xenograft Model Identifies Topotecan as a Potential Chemotherapeutic Agent (2013) (27)
- Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study. (2017) (26)
- Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma. (2005) (26)
- Racial and Ethnic Disparities in the Incidence of Pediatric Extracranial Embryonal Tumors (2017) (25)
- p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor. (2009) (25)
- Developmental and adaptive functioning in children with retinoblastoma: a longitudinal investigation. (2014) (25)
- Pediatric adrenocortical tumours. (2020) (24)
- Cost‐benefit analysis of implementing a pediatric early warning system at a pediatric oncology hospital in a low‐middle income country (2019) (24)
- Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutation (2011) (24)
- Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study. (2019) (23)
- Monitoring carboplatin ototoxicity with distortion-product otoacoustic emissions in children with retinoblastoma. (2010) (23)
- Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors (2017) (23)
- Colorimetric and Longitudinal Analysis of Leukocoria in Recreational Photographs of Children with Retinoblastoma (2013) (23)
- The effect of cancer therapies on pediatric anophthalmic sockets. (2011) (22)
- Local control in childhood extremity sarcomas: salvaging limbs and sparing function. (2003) (22)
- How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country: Analysis of 478 Patients. (2020) (22)
- Validation of a multi‐modal treatment protocol for Ewing sarcoma—A report from the polish pediatric oncology group (2014) (21)
- Pediatric hematology-oncology in countries with limited resources : (2014) (21)
- Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey (2018) (21)
- Prognostic Significance of Major Histocompatibility Complex Class II Expression in Pediatric Adrenocortical Tumors: A St. Jude and Children's Oncology Group Study (2016) (21)
- Treatment of childhood adrenocortical carcinoma (ACC) with surgery plus retroperitoneal lymph node dissection (RPLND) and multiagent chemotherapy: Results of the Children’s Oncology Group ARAR0332 protocol. (2016) (21)
- Transfer of complex frontline anticancer therapy to a developing country: The St. Jude osteosarcoma experience in Chile (2008) (20)
- Treating Pediatric soft tissue sarcomas in a country with limited resources: The experience of the Unidad Nacional de Oncologia Pediatrica in Guatemala (2008) (20)
- Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma (2008) (20)
- Socioeconomic status and global variations in the incidence of neuroblastoma: call for support of population‐based cancer registries in low‐middle–income countries (2017) (20)
- Brain metastases in children with melanoma (1997) (20)
- Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors (2005) (19)
- Successful treatment of early detected trilateral retinoblastoma using standard infant brain tumor therapy (2010) (19)
- Comparison of two methods for carboplatin dosing in children with retinoblastoma (2010) (19)
- Retinoblastoma in a patient with an X;13 translocation and facial abnormalities consistent with 13q-syndrome. (2002) (19)
- Internal hemipelvectomy in the management of pelvic Ewing sarcoma - are outcomes better than with radiation therapy? (2014) (18)
- Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group (2017) (18)
- Corneal juvenile xanthogranuloma in a 4-month-old child. (2003) (18)
- Myogenic tumors in nevoid Basal cell carcinoma syndrome. (2015) (18)
- Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults? (2018) (18)
- Displaced children with cancer in Lebanon: A sustained response to an unprecedented crisis (2018) (18)
- A phase IIa study of afuresertib, an oral pan‐AKT inhibitor, in patients with Langerhans cell histiocytosis (2017) (18)
- Immunohistochemical Expression of CRX in Extracranial Malignant Small Round Cell Tumors (2012) (18)
- Effect of Fractionated Ifosfamide on the Pharmacokinetics of Irinotecan in Pediatric Patients With Osteosarcoma (2004) (18)
- Management and follow-up of Ewing sarcoma patients with isolated lung metastases. (2016) (17)
- Ovarian function in female survivors after multimodal Ewing sarcoma therapy (2015) (17)
- Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol (2021) (17)
- Suppression of c-myc expression and c-Myc function in response to sustained DNA damage in MCF-7 breast tumor cells. (2001) (17)
- Local control of the primary tumour in metastatic neuroblastoma. (2009) (16)
- Things that matter: Adolescent and young adult patients’ priorities during cancer care (2019) (16)
- Germline TP53 R337H mutation is not sufficient to establish Li-Fraumeni or Li-Fraumeni-like syndrome. (2007) (16)
- Germline Variants in Phosphodiesterase Genes and Genetic Predisposition to Pediatric Adrenocortical Tumors (2020) (16)
- Qualitative Study of Pediatric Early Warning Systems’ Impact on Interdisciplinary Communication in Two Pediatric Oncology Hospitals With Varying Resources (2020) (16)
- Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect? (2007) (16)
- A longitudinal investigation of parenting stress in caregivers of children with retinoblastoma (2017) (16)
- Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group Study. (2016) (15)
- Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors. (2014) (15)
- Intensive multi-modality therapy for extra-ocular retinoblastoma (RB): A Children's Oncology Group (COG) trial (ARET0321). (2017) (15)
- The Cost-effectiveness of Gene Therapy for Severe Hemophilia B: Microsimulation Study from the United States Perspective. (2021) (15)
- Functional neuroimaging to characterize visual system development in children with retinoblastoma. (2011) (15)
- Clinical and organizational risk factors for mortality during deterioration events among pediatric oncology patients in Latin America: A multicenter prospective cohort (2021) (15)
- Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma. (2001) (15)
- Retinoblastoma metastatic to the ovary in a patient with Waardenburg syndrome. (2002) (15)
- 5th International ACC Symposium: Hereditary Predisposition to Childhood ACC and the Associated Molecular Phenotype (2016) (14)
- Addressing regional disparities in pediatric oncology: Results of a collaborative initiative across the Mexican–North American border (2017) (14)
- Clinical features and treatment of Langerhans cell histiocytosis (2021) (14)
- Aggressive treatment and survival outcomes in NUT midline carcinoma (NMC) of the head and neck (HN). (2014) (13)
- Malignant glomus tumors of the head and neck in children and adults: Evaluation and management (2017) (13)
- Pediatric Early Warning Systems aid in triage to intermediate versus intensive care for pediatric oncology patients in resource‐limited hospitals (2018) (13)
- Predictive factors of invasion in eyes with retinoblastoma enucleated after eye salvage treatments (2009) (13)
- Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group. (2017) (13)
- Impact of the COVID‐19 pandemic on pediatric oncology providers globally: A mixed‐methods study (2022) (12)
- Solid Cancers in the Premature and the Newborn: Report of Three National Referral Centers. (2016) (12)
- Synchronous and Metachronous Thyroid Cancer in Relation to Langerhans Cell Histiocytosis; Involvement of V600E BRAF-Mutation? (2014) (12)
- Sister Mary Joseph's nodule as presenting sign of a desmoplastic small round cell tumor (2008) (12)
- Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study (2018) (12)
- Expression of the Multi-Drug Resistance Proteins and the Pregnane X Receptor in Treated and Untreated Retinoblastoma (2009) (12)
- Pharmacological management of Ewing sarcoma family of tumours (2004) (12)
- Granulocyte‐macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemia (2005) (12)
- Primary malignant peripheral nerve sheath tumor of the lung in a young child without neurofibromatosis type 1 (2006) (11)
- Influence of early phase clinical trial enrollment on patterns of end‐of‐life care for children with advanced cancer (2018) (11)
- Liposomal doxorubicin: Effective treatment for pediatric desmoid fibromatosis (2017) (11)
- The Global COVID‐19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global (2021) (11)
- Spatial trends in congenital malformations and stream water chemistry in Southern Brazil. (2019) (11)
- Imaging pediatric oncologic emergencies of the abdomen. (1999) (11)
- Impact of PEWS on Perceived Quality of Care During Deterioration in Children With Cancer Hospitalized in Different Resource-Settings (2021) (10)
- Incidence of Anemia in Children With Solid Tumors or Hodgkin Disease (2002) (10)
- Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion–negative rhabdomyosarcoma: A report from the Children's Oncology Group (2018) (10)
- Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course (2016) (10)
- Clinician Emotions Surrounding Pediatric Oncology Patient Deterioration (2021) (10)
- Bronchioloalveolar carcinoma as a second malignancy in osteosarcoma survivors (2009) (9)
- Evaluation Of Afuresertib, An Oral Pan-AKT Inhibitor, In Patients With Langerhans Cell Histiocytosis (2013) (9)
- Intra-Arterial Cisplatin in Osteosarcoma: Same Question, Different Answer (2003) (9)
- Ipilimumab: First results of a phase I trial in pediatric patients with advanced solid tumors. (2012) (9)
- Enucleation for retinoblastoma: the experience of a single center in Jordan (2010) (9)
- Langerhans cell histiocytosis (1998) (9)
- The challenge of very rare childhood cancers in developed and developing countries (2017) (9)
- Carboplatin (CBP) versus cisplatin (CP) within prognostic groups in pediatric extracranial malignant germ cell tumors (MGCTs). (2012) (8)
- Imaging aspects of neurologic emergencies in children treated for non-CNS malignancies (2000) (8)
- Resilient health care in global pediatric oncology during the COVID‐19 pandemic (2021) (8)
- Treatment of childhood nasopharyngeal carcinoma (cNPC) with neoadjuvant chemotherapy (NAC) and concomitant chemoradiotherapy (CCRT): Results of the Childrens Oncology Group ARAR0331 study. (2016) (8)
- Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study (2018) (8)
- Heme oxygenase-1 messenger RNA expression is induced in peripheral blood mononuclear cells of pediatric cancer patients with systemic inflammatory response syndrome (2004) (8)
- Trisomy of the Long Arm of Chromosome 1 Resulting in a Dicentric Derivative (6)t(1;6) Chromosome in a Child with Myelodysplastic Syndrome Following Treatment for a Primitive Neuroectodermal Tumor (2000) (7)
- Delayed Diagnosis and False Relapse Due to Paternal Testosterone Use in Adrenocortical Carcinoma (2014) (7)
- Translating Discovery into Cures for Children with Cancer Childhood Cancer Research Landscape Report (2016) (7)
- Retrospective study of the surgical management and outcome of nonrhabdomyosarcoma soft tissue sarcomas of the groin and axilla in children. (2009) (7)
- Pyogenic hepatic abscess after percutaneous liver biopsy in a patient with sickle cell disease. (2005) (7)
- The basics of retinoblastoma: Back to school (2011) (7)
- Pediatric cancer communication in low‐ and middle‐income countries: A scoping review (2020) (7)
- Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma (2018) (7)
- Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children's Oncology Group. (2019) (6)
- α‐Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium (2019) (6)
- Bridging the Gap in Access to Care for Children With CNS Tumors Worldwide (2020) (6)
- Participation in an occupational therapy referral program for children with retinoblastoma. (2016) (6)
- Risk of second malignant neoplasms in women and girls with germ cell tumors (2016) (6)
- From Upfront Nephrectomy to Preoperative Chemotherapy and Back: A Single Institution Experience in the Treatment of Wilms Tumor (2009) (6)
- Pediatric anophthalmic sockets and orbital implants: outcomes with polymer-coated implants. (2013) (6)
- Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium (2020) (6)
- Influence of early-phase clinical trial enrollment on patterns of end-of-life care for children with advanced cancer. (2016) (6)
- Hope for African children with cancer: African pediatric oncology group (2012) (6)
- Nasopharyngeal carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations (2021) (6)
- Treatment of Langerhans cell histiocytosis: it is time to learn from the past (2015) (5)
- Model for regional collaboration: Successful strategy to implement a pediatric early warning system in 36 pediatric oncology centers in Latin America (2022) (5)
- Doxorubicin in combination with cisplatin, 5‐flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study (2021) (5)
- Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution. (2009) (5)
- Multicenter study assessing tumor molecular profiles in advanced pediatric solid tumors. (2014) (5)
- The evolution of parents’ beliefs about childhood cancer during diagnostic communication: a qualitative study in Guatemala (2021) (5)
- Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis. (2021) (5)
- Joining forces for children with cancer in Latin America. (2016) (5)
- Pediatric Solid Tumors (2020) (5)
- Correlation Between MYCN Gene Status and MYCN Protein Expression in Neuroblastoma: A Pilot Study To Propose the Use of MYCN Immunohistochemistry in Limited-Resource Areas (2019) (5)
- Efficacy of definitive irradiation and multi-agent systemic therapy for localized ewing’s sarcoma family of tumors (ESFT) (2003) (5)
- development of a therapeutic approach to rare cancers in children: the Children's Oncology Group experience. (2012) (5)
- IVADo treatment of type II and type III pleuropulmonary blastoma (PPB): A report from the International PPB Registry. (2014) (4)
- A sustainable model for pediatric oncology nursing education and capacity building in Latin American hospitals: Evolution and impact of a nurse educator network (2021) (4)
- Communication Priorities and Experiences of Caregivers of Children With Cancer in Guatemala (2021) (4)
- Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors. (2014) (4)
- Development, Implementation, and Outcomes of a Global Infectious Disease Training Course (2021) (4)
- Thrombocytosis in an infant with high thrombopoietin concentrations. (2004) (4)
- Paediatric Oncology System Integration Tool (POSIT) for the joint analysis of the performance of childhood cancer programs and health systems (2020) (4)
- Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. (2021) (4)
- Cancer care for children in the Gaza Strip. (2021) (4)
- Improving Immunohistochemistry Capability for Pediatric Cancer Care in the Central American and Caribbean Region: A Report From the AHOPCA Pathology Working Group (2018) (4)
- Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient (2018) (3)
- Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage (2022) (3)
- The Langerhans cell histiocytosis: a disease in search of an identity (2011) (3)
- Creation of a successful multidisciplinary course in pediatric neuro‐oncology with a systematic approach to curriculum development (2020) (3)
- Pediatric Early Warning Systems (PEWS) improve provider‐family communication from the provider perspective in pediatric cancer patients experiencing clinical deterioration (2022) (3)
- Second Malignancies and Other Long Term Effects in Retinoblastoma Survivors (2010) (3)
- Ewing sarcoma: investigational mono- and combination therapies in clinical trials (2021) (3)
- The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA (2021) (3)
- Impact of central surgical review in a study of malignant germ cell tumors. (2015) (3)
- Chemotherapy in the Management of Retinoblastoma (2010) (3)
- Vincristine/irinotecan upfront window treatment of high-risk hepatoblastoma: A report from the Children’s Oncology Group (COG) AHEP0731 study committee. (2016) (3)
- Subsequent Malignant Neoplasm of Bone in Children and Adolescent—Possibility of Multimodal Treatment (2022) (3)
- Cognitive and Adaptive Functioning in Youth With Retinoblastoma: A Longitudinal Investigation Through 10 Years of Age (2021) (3)
- Open letter to Lady Scotland. (2017) (3)
- Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's oncology group trial, AHEP0731. (2022) (2)
- Ewing sarcoma family tumors (ESFT) as second malignant neoplasms (SMN) following treatment of a primary malignant neoplasm (PMN) during childhood (2004) (2)
- Risk of second gonadal cancers in women and children with germ cell tumors (2016) (2)
- Langerhans cell histiocytosis: What's at the heart of the matter? (2013) (2)
- Maintenance Treatment with Trofosfamide in Patients with Primary Bone Ewing Sarcoma – Single Center Experience (2019) (2)
- Delivery of radiation therapy in resource‐limited settings: A pilot quality assessment study (2017) (2)
- Alfa-feto protein (AFP) as a predictor of outcome for children with germ cell tumors: A report from the malignant germ cell international consortium. (2019) (2)
- Cancer care for displaced children from Venezuela. (2021) (2)
- Adrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment (2021) (2)
- Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321) (2022) (2)
- O059 / #669: MODEL FOR REGIONAL COLLABORATION IN QUALITY IMPROVEMENT: IMPLEMENTATION OF A PEDIATRIC EARLY WARNING SYSTEM IN 17 PEDIATRIC ONCOLOGY CENTERS IN LATIN AMERICA AND THE CARIBBEAN (2021) (2)
- EPID-07. A GLOBAL PERSPECTIVE ON THE BURDEN OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS (2020) (2)
- A Phase I Study of Gefitinib and irinotecan (IRN) in pediatric patients with refractory solid tumors. (2004) (2)
- Retinoblastoma-Clinical Spectrum and Treatment Outcome in Children (2016) (2)
- Ifosfamide, carboplatin, and etoposide as front-line therapy in patients with Ewing sarcoma family tumors (EFT): A study of the Brazil/Uruguay Cooperative Group. (2016) (2)
- A Phase I Study of Gefitinib and irinotecan (IRN) in pediatric patients with refractory solid tumors (2004) (2)
- The Toronto Guidelines: a practical means for childhood cancer staging. (2018) (2)
- Current treatment of Langerhans cell histiocytosis (2016) (2)
- Successful Implementation of a Pediatric Early Warning Score in a Resource-Limited Pediatric Oncology Hospital in Guatemala (2016) (2)
- The Common Germline TP53-R337H Mutation Is Hypomorphic and Confers Incomplete Penetrance and Late Tumor Onset in a Mouse Model (2021) (2)
- Abstract 999: The genomic landscape of pediatric Ewing sarcoma (2014) (2)
- Effective treatment of cytomegalovirus retinitis and neuritis with retrobulbar ganciclovir after treosulfan-based autologous bone marrow transplant. (2015) (2)
- Uncommon Adrenal Tumors in Children and Adolescents (2012) (2)
- Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors (2021) (2)
- Training pediatric hematologist/oncologists for capacity building in Ethiopia (2020) (2)
- BRAF-V600E in Peripheral Mononuclear Cells and Microglia-like Brain Cells Suggest Hematopoietic Origin of Langerhans Cell Histiocytosis-Associated Neurodegeneration (2017) (1)
- Less-Frequently Encountered Tumors of Childhood (2003) (1)
- Uncommon Endocrine Tumors in Children and Adolescents (2006) (1)
- Rising drug cost impacts on cost‐effectiveness of 2 chemotherapy regimens for intermediate‐risk rhabdomyosarcoma: A report from the Children's Oncology Group (2021) (1)
- [Chemotherapy in patients with refractory Ewing sarcoma]. (2013) (1)
- The cost and cost-effectiveness of a pediatric cancer unit (PCU) in the context of universal health coverage (UHC): A report from the Childhood Cancer 2030 Network. (2018) (1)
- p 18 Ink 4 c and p 53 Act as Tumor Suppressors in Cyclin D 1 – Driven Primitive Neuroectodermal Tumor (2009) (1)
- Psychosocial outcomes and quality of life among school‐age survivors of retinoblastoma (2022) (1)
- Outcomes of adolescent males with extracranial malignant germ cell tumors compared with children and young adults: A report from the Malignant Germ Cell Tumors International Consortium (MaGIC) group. (2019) (1)
- Ewing sarcoma and its many faces: are we close to a cure? (2013) (1)
- Rate of MYC-N gene amplification among children of Middle Eastern descent with neuroblastoma. (2018) (1)
- Situation analysis of problems and prospects of the pediatric hematology-oncology in the CIS countries: the experience of a joint working group (2018) (1)
- Assessment of Retinoblastoma Capacity in the Middle East, North Africa, and West Asia Region (2020) (1)
- Clinical and Functional Significance of TP53 Exon 4–Intron 4 Splice Junction Variants (2021) (1)
- The Role of Registries and Tumor Banking in Rare Pediatric Tumors (2015) (1)
- Analysis of somatic copy number alterations in pediatric solid tumors using array comparative genomic hybridization. (2014) (1)
- Chapter 69 – Retinoblastoma (2012) (1)
- Reply to G. Mangili et al and C. Lhommé et al. (2014) (1)
- Multinational Retrospective Central Pathology Review of Neuroblastoma: Lessons Learned to Establish a Regional Pathology Referral Center in Resource-Limited Settings. (2021) (1)
- Early death in pediatric cancer: remaining questions and next steps (2017) (1)
- Intra-arterial chemotherapy for rhabdomyosarcoma (2021) (1)
- Clinical Outcomes and Molecular Responses in Children with Langerhans Cell Histiocytosis Treated with MAPK Pathway Inhibitors (2018) (1)
- Pediatric Langerhans Cell Histiocytosis (LCH) Clinical Outcome in Hospital Civil De Guadalajara, México (2018) (1)
- Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war. (2022) (1)
- Distal Tibial Reconstruction in the Management of Primary Bone Tumors in Children and Adolescents (2021) (1)
- Is Adjuvant Chemotherapy necessary in Ovarian Immature Teratoma? A Combined Data Analysis from The Malignant Germ Cell Tumors International Collaborative (MaGIC) (2015) (1)
- Blue toe syndrome: a complication of intra-arterial technique, not intra-arterial chemotherapy for retinoblastoma. (2014) (1)
- Carboplatin and Vincristine as Primary Systemic Chemotherapy for Intraocular Retinoblastoma: A Review of 82 Consecutively Treated Eyes. (2004) (1)
- Outcomes of Children With Low-Grade Gliomas in Low- and Middle-Income Countries: A Systematic Review (2022) (1)
- Birth and maternal characteristics, and childhood cancer in the United States: An ecological study. (2013) (1)
- Evaluation of Early Treatment Response Utilizing the MAS-ALL18 Adapted Management Guideline in Four "Mexico in Alliance with St. Jude" (MAS) Member Hospitals (2021) (1)
- 1.O.02 COMPARING ADULT AND PEDIATRIC RHABDOMYOSARCOMA IN THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM, 1973–2005: AN ANALYSIS OF 2600 CASES (2010) (1)
- Cost and Cost-Effectiveness of Childhood Cancer Treatment in El Salvador: A Collaborative Budget Model (2017) (1)
- A phase II study of sirolimus and erlotinib in recurrent/refractory germ cell tumors. (2014) (1)
- Socioeconomic status and incidence of pediatric embryonal tumors in the United States. (2013) (0)
- Molecular and MRD-Based Characterization of Acute Lymphoblastic Leukemia in Mexico: Experience from the Mexico in Alliance with St. Jude "Bridge Project" (2021) (0)
- Lineage-switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis. (2022) (0)
- THYROID CANCER IN LEBANESE CHILDREN AND ADOLESCENTS: A 15-Year Experience at a Single Institution (2009) (0)
- Principles of Treatment (2003) (0)
- A Prospective Single Institution Trial Using Toptecan Based Chemotherapy for the Treatment of Bilateral Intraocular Retinoblastoma: 5 Year Results. (2014) (0)
- Rare Tumors of the Peripheral Nervous System (2012) (0)
- Table 7.2, Infrastructure Needed to Deliver Ideal Pediatric Cancer Care in Low- and Middle-Income Countriesa (2015) (0)
- The effect of topotecan in advanced intraocular retinoblastoma with manageable toxicity. (2011) (0)
- 1407: CRITICAL DETERIORATION PREDICTS PICU OUTCOMES IN PEDIATRIC HEMATOLOGY-ONCOLOGY AND HSCT PATIENTS (2019) (0)
- Table 7.7, Selected Cohorts and Outcomes of Children with Burkitt Lymphoma Treated in Low- and Middle-Income Countries with Locally Adapted Protocols of Lower Intensity (2015) (0)
- Contribution of the TP53 R337H mutation to the cancer burden in families with a proband with adrenocortical tumor. (2016) (0)
- Heritable cancer predisposition testing in pediatric cancer patients excluding retinoblastoma in a middle‐income country (2022) (0)
- Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma. (J Med Genet (2008) 45 (603-6)) (2009) (0)
- Global Impact of the COVID-19 Pandemic on Paediatric Cancer Care (2020) (0)
- Molecular and Cellular Pathobiology Suppression of Deacetylase SIRT 1 Mediates Tumor-SuppressiveNOTCHResponse andOffers aNovel Treatment Option in Metastatic Ewing Sarcoma (2014) (0)
- Monitoring Carboplatin Ototoxicity in Children with Distortion-Product Otoacoustic Emissions: A Feasibility Study (2010) (0)
- Title : Paediatric Extracranial Germ Cell Tumours (2016) (0)
- Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee. (2023) (0)
- Adrenocortical Tumors in Children Lead contributors : (2008) (0)
- Cancer treatment decision-making among parents of paediatric oncology patients in Guatemala: a mixed-methods study (2022) (0)
- 120: PATTERNS OF DETERIORATION IN HOSPITALIZED PEDIATRIC ONCOLOGY PATIENTS REQUIRING ICU ADMISSION. (2014) (0)
- Anterior Versus Posterior Tumors in Patients with Retinoblastoma Treated with Primary Systemic Chemotherapy (2003) (0)
- DEV-09. ST. JUDE GLOBAL ACADEMY NEURO-ONCOLOGY SEMINAR: THE CREATION OF A TARGETED CURRICULUM FOR GLOBAL NEURO-ONCOLOGY (2018) (0)
- Table 7.3, Characteristics of Childhood Cancers to Consider When Determining Which Malignancies Are Appropriate for Treatment in a Particular Resource-Constrained Setting (2015) (0)
- Impact of treatment refusal and abandonment on survival outcomes in pediatric osteosarcoma in Southeast Asia: A multicenter study (2022) (0)
- Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults (AYA): A population-based study. (2012) (0)
- Pregnane X Receptor Expression in Untreated and Treated Retinoblastoma (2007) (0)
- Abstract 3405: Caveolin-1 modulates the metastatic ability of Ewing's sarcoma (2010) (0)
- Erratum to: Adolescents and Young Adults With a “Rare” Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors (The Oncologist, (2014), 19, 7, (689-692), 10.1634/theoncologist.2014-0009) (2018) (0)
- Increased risk of second malignant neoplasms (SMN) in young children with embryonal rhabdomyosarcoma (ERMS): Evidence for a cancer predisposition syndrome? (2014) (0)
- Imaging in Pediatric Oncology: New Advances and Techniques (2019) (0)
- RNA profiling of desmoplastic small round cell tumors (DSRCTs) using next-generation sequencing. (2016) (0)
- Postrecurrence survival for pediatric extracranial malignant germ cell tumors: A report from the Malignant Germ Cell Tumors International Collaborative (MaGIC) Group. (2014) (0)
- Alpha-fetoprotein (AFP) as a predictor of outcome for children with germ cell tumours: A report from the Malignant Germ Cell International Consortium (MaGIC) (2019) (0)
- Original Article50 Years Ago in The Journal of Pediatrics: Approaches to the Chemical Therapy of Tumors (2009) (0)
- Issue Information (2021) (0)
- Iconography : Clinical Characteristics and Treatment of Langerhans Cell Histiocytosis (2015) (0)
- Adolescents and Young Adults With a “Rare” Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors (2018) (0)
- Abstract B17: Identification of Druggable Targets through Functional Multi-Omics in Renal Medullary Carcinoma (2017) (0)
- An exploratory study of sleep habits in school-aged survivors of retinoblastoma. (2023) (0)
- Risk of second thyroid cancer (STC) among survivors of childhood cancer. (2014) (0)
- Evaluating blinatumomab implementation in low- and middle-income countries: a study protocol (2022) (0)
- Ewing sarcoma family tumors (ESFT) as second malignant neoplasms (SMN) following treatment of a primary malignant neoplasm (PMN) during childhood. (2004) (0)
- Table 7.5, Classification of Different Settings Providing Care for Children with Wilms Tumora (2015) (0)
- Pre-Enucleation Chemotherapy in Advanced Intraocular Retinoblastoma. Central America Follow Up: AHOPCA II (2016) (0)
- Ewing Sarcoma Family of Tumors Lead contributors : (2009) (0)
- Implementation of pediatric population-based cancer registries (PBCR) in Central America (CA). (2015) (0)
- Colorimetric Image Analysis in Detection of Leukocoria from Retinoblastoma in Snapshots Taken by Standard Digital Photography (2013) (0)
- Adrenocortical Cancer in Children (2009) (0)
- 95 – Pediatric Solid Tumors (2014) (0)
- Effective treatment of severe hypertensive crisis in 2-year-old child with neuroblastoma (2015) (0)
- Figure 7.3, Cost-Effective Thresholds Compared with Actual Costs in Selected Pediatric Malignancies (2015) (0)
- CONSENSUS-BASED PRINCIPLES AND CLASSIFICATION SYSTEMS FOR COLLECTING PAEDIATRIC CANCER STAGE IN POPULATION-BASED CANCER REGISTRIES (2015) (0)
- TheCOVID-19PANDEMIC:ARapidGlobalresponsefor ChildrenwithCancerfrom SIOP,COG,SIOP-E,SIOP-PODC,IPSO,PROS, CCIandStJudeGlobal (2020) (0)
- Comprar Biology and Treatment of Retinoblastoma | Rodriguez-Galindo, Carlos | 9780387890715 | Springer (2010) (0)
- LINC-35. THE ST. JUDE GLOBAL ACADEMY NEURO-ONCOLOGY TRAINING SEMINAR: A MULTIDISCIPLINARY, INTERNATIONAL EDUCATION PROGRAM (2020) (0)
- Author reply (1998) (0)
- Maintenance treatment with trofosfamide in patients with primary bone ewing sarcoma - single center experience. (2021) (0)
- Abstract P-120: CHARACTERISTICS AND MORTALITY OF CLINICAL DETERIORATION EVENTS IN PEDIATRIC ONCOLOGY PATIENTS HOSPITALIZED IN RESOURCE-LIMITED SETTINGS A MULTICENTER STUDY (2018) (0)
- Development and Adaptation of a Patient-Centered Communication Survey for Parents of Children With Cancer in Guatemala (2022) (0)
- Correlation of insurance status, ethnicity, and race with pathologic risk in retinoblastoma: A Children's Oncology Group (COG) study. (2013) (0)
- Death less than one month from diagnosis in children with cancer: A population-based analysis. (2014) (0)
- Chapter 71 – Retinoblastoma (2016) (0)
- Acknowledgment of Reviewers, 2018 (2018) (0)
- Evaluation of the necessity of bilateral bone marrow aspirates and biopsies for the diagnosis of metastatic disease in pediatric patients with solid tumors. (2013) (0)
- Abstract B38: Developing a functional genomics platform to interrogate rare pediatric cancers (2016) (0)
- Reply to J.-G. Wang et al. (2021) (0)
- Rhabdomyosarcoma in low- and middle-income countries: A report from the Asociacion de Hemato-oncología Pediatrica de Centro América (AHOPCA). (2022) (0)
- Abstract 10: The Evolution of Parents' Beliefs about Childhood Cancer: A Qualitative Study in Guatemala (2021) (0)
- Current concepts in the treatment of Langerhans Cell Histiocytosis (2008) (0)
- Table 7.1, Examples of Essential Personnel for Ideal Pediatric Cancer Care in Low- and Middle-Income Countriesa (2015) (0)
- Figure 7.1, Links in the Chain of Childhood Cancer Diagnosis and Registration with Potential Barriers in Low- and Middle-Income Countries (2015) (0)
- The burden and scope of childhood cancer in displaced patients in Jordan: The King Hussein Cancer Center and Foundation Experience (2023) (0)
- Cure4Kids: Two decades of knowledge transfer (2022) (0)
- First-Line Treatment of Pediatric Langerhans Cell Histiocytosis (2018) (0)
- Elevated risk of second malignant neoplasms in pediatric germ cell tumor patients. (2013) (0)
- PyogenicHepatic Abscess After Percutaneous Liver Biopsy in a Patient With Sickle Cell Disease (2005) (0)
- CHAPTER 71 – Non-ocular tumors (2007) (0)
- #68: Outcomes of Establishing Infection Care and Prevention Standards in Pediatric Oncology Units in Three Hospitals on the Island of Hispaniola (2021) (0)
- Box 7.2, Examples of Successful Efforts to Decrease the Abandonment of Therapy in Children with Cancer (2015) (0)
- Multidrug Resistant Protein Expression in Untreated Retinoblastoma (2005) (0)
- Carcinomas in the children and young adults: A report form Children’s Oncology Group APEC14B1 study. (2019) (0)
- health-related indicators countries impact of socioeconomic and Survival of retinoblastoma in less-developed (0)
- Understanding hope at diagnosis: A study among Guatemalan parents of children with cancer. (2023) (0)
- Multidrug Resistant Protein Expression in Untreated and Treated Retinoblastoma (2006) (0)
- Germ cell tumors (1976) (0)
- Table 7.4, Treatment Results of Pediatric Hodgkin Lymphoma Trials in Low- and Middle-Income Countries (2015) (0)
- Pediatric cancer communication in Guatemala. (2021) (0)
- COVD-04. CHARACTERISTICS OF SARS-COV-2 IN 64 CHILDREN WITH CNS TUMORS: A REPORT FROM THE SIOP/ST. JUDE CHILDREN’S RESEARCH HOSPITAL (SJCRH) GLOBAL COVID-19 CHILDHOOD CANCER REGISTRY (2020) (0)
- Topotecan Penetrates Rabbit Vitreous After Systemic Administration (2003) (0)
- Changes in incidence of infant cancer: Analysis of SEER data 1992-2007. (2011) (0)
- Genomic landscape of pediatric adrenocortical tumors article available. Please share how this access benefits you. Your story matters (2015) (0)
- Abstract B40: Mouse clinical trials: integrating PDX models of sarcoma subtypes with genomics to replicate patient responses to cancer therapeutics (2016) (0)
- Sarcoma: Non-Rhabdomyosarcoma Soft Tissue Sarcomas (2014) (0)
- Figure 7.2, Reported Incidence Rate of Childhood Leukemia and Its Association with 2005 Gross National Income, Selected Economies (2015) (0)
- Cancer Therapy : Clinical Clinicopathologic Features and Long-termOutcomes of NUT Midline Carcinoma (2012) (0)
- Table 7.6, Reported Outcomes of Patients with Wilms Tumor Treated in Low- and Middle-Income Countries (2015) (0)
- Predictors and Treatment Outcomes of Pediatric Osteosarcoma in Diverse Socioeconomic Backgrounds in Southeast Asia: A Retrospective Multicenter Study (2022) (0)
- Cancer Therapy : Preclinical Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma Xenograft Model Identi fi es Topotecan as a Potential Chemotherapeutic Agent (2013) (0)
- Malignant Tumors of the Skin and Subcutaneous Tissue in Children (2012) (0)
- Impact of socioeconomic status on extent of disease at diagnosis and cancer and ocular outcomes in retinoblastoma: A population-based analysis. (2013) (0)
- High Risk Histology in Eyes of Patients With Unilateral Retinoblastoma (2010) (0)
- Multinational Retrospective Central Pathology Review of Neuroblastoma: Lessons Learned to Establish a Regional Pathology Referral Center in Resource-Limited Settings. (2020) (0)
- 811: VALIDATION OF A PEDIATRIC EARLY WARNING SCORE (PEWS) IN PEDIATRIC ONCOLOGY PATIENTS (2015) (0)
- Ethnic disparities in pediatric Ewing sarcoma and osteosarcoma. (2014) (0)
- Prognostic Factors for High Risk Histology Following Chemoreduction for Retinoblastoma (2008) (0)
- #80: Developing and Implementing an Infectious Diseases Training Seminar for Global Healthcare Providers for Children with Cancer (2021) (0)
- Carcinomas and Melanoma (2003) (0)
- Treatment of Relapsed and Refractory Langerhans Cell Histiocytosis in Children (2018) (0)
- Chapter 7 – Pulmonary Manifestations of Hematologic and Oncologic Diseases (2009) (0)
- Characterization of Visual System Development in Children With Retinoblastoma Using Functional Neuroimaging (2008) (0)
- Table 7.8, Comparison of Cost-Effectiveness Thresholds among Common Childhood Cancers, Selected Countries (2015) (0)
- Non-ocular Tumors (2015) (0)
- 1191: VALIDATION OF A PEDIATRIC EARLY WARNING SCORE IN A PEDIATRIC ONCOLOGY HOSPITAL IN GUATEMALA (2016) (0)
- Open-label, multicenter, single-arm, phase I, dose-dscalation with efficacy tail extension study of vemurafenib in pediatric patients with surgically incurable and unresectable stage IIIc or IV melanoma harboring BRAFV600 mutations (NCT01519323). (2013) (0)
- NUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendations (2022) (0)
- Survival estimates of childhood malignancies treated at the Mexican telethon pediatric oncology hospital (2022) (0)
- Outcomes of adolescent males with extracranial metastatic germ cell tumours compared with children and young adults: A report from the Malignant Germ Cell Tumour International Consortium (MaGIC) group (2019) (0)
- CHAPTER 72 – Trilateral retinoblastoma (2007) (0)
- Treatment o f I ntraocular R etinoblastoma W ith V incristine and C arboplatin (2003) (0)
- Abstract 2530: Incidence trends of childhood and adolescent melanoma in the United States from 1973-2009. (2013) (0)
This paper list is powered by the following services: